Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 25% ± 9% | |
microglial cell | 5 studies | 23% ± 4% | |
astrocyte | 5 studies | 28% ± 8% | |
GABAergic neuron | 4 studies | 42% ± 17% | |
glutamatergic neuron | 4 studies | 51% ± 20% | |
oligodendrocyte precursor cell | 4 studies | 32% ± 8% | |
fibroblast | 4 studies | 22% ± 4% | |
oligodendrocyte | 4 studies | 20% ± 5% | |
macrophage | 3 studies | 24% ± 4% | |
pericyte | 3 studies | 18% ± 3% | |
neuron | 3 studies | 35% ± 13% | |
interneuron | 3 studies | 38% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 39% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 876.55 | 1445 / 1445 | 100% | 13.58 | 183 / 183 |
skin | 100% | 1501.60 | 1809 / 1809 | 100% | 16.62 | 471 / 472 |
breast | 100% | 1120.49 | 459 / 459 | 99% | 15.83 | 1112 / 1118 |
ovary | 100% | 1312.17 | 180 / 180 | 99% | 16.03 | 426 / 430 |
lung | 100% | 991.80 | 578 / 578 | 99% | 11.62 | 1144 / 1155 |
prostate | 100% | 1121.94 | 245 / 245 | 99% | 11.88 | 496 / 502 |
intestine | 100% | 992.54 | 966 / 966 | 99% | 10.12 | 520 / 527 |
stomach | 100% | 837.05 | 359 / 359 | 99% | 11.23 | 282 / 286 |
thymus | 100% | 1699.66 | 653 / 653 | 99% | 12.90 | 596 / 605 |
bladder | 100% | 1084.05 | 21 / 21 | 98% | 9.91 | 495 / 504 |
pancreas | 100% | 841.38 | 328 / 328 | 97% | 8.87 | 172 / 178 |
kidney | 100% | 708.00 | 89 / 89 | 96% | 11.07 | 869 / 901 |
brain | 97% | 491.27 | 2553 / 2642 | 100% | 15.47 | 703 / 705 |
uterus | 100% | 1311.65 | 170 / 170 | 96% | 9.39 | 442 / 459 |
adrenal gland | 100% | 985.63 | 258 / 258 | 95% | 10.86 | 219 / 230 |
liver | 100% | 460.96 | 226 / 226 | 77% | 4.95 | 313 / 406 |
adipose | 100% | 1054.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 17.06 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.44 | 29 / 29 |
spleen | 100% | 903.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.10 | 1 / 1 |
blood vessel | 100% | 1062.08 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 489.69 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 544.75 | 826 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 64% | 366.70 | 596 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0060271 | Biological process | cilium assembly |
GO_0016567 | Biological process | protein ubiquitination |
GO_0007030 | Biological process | Golgi organization |
GO_0008283 | Biological process | cell population proliferation |
GO_0050775 | Biological process | positive regulation of dendrite morphogenesis |
GO_0060716 | Biological process | labyrinthine layer blood vessel development |
GO_0005814 | Cellular component | centriole |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0031467 | Cellular component | Cul7-RING ubiquitin ligase complex |
GO_1990393 | Cellular component | 3M complex |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FBXW8 |
Protein name | F-box and WD repeat domain containing 8 F-box/WD repeat-containing protein 8 (F-box and WD-40 domain-containing protein 8) (F-box only protein 29) |
Synonyms | FBW6 FBXO29 FBXW6 FBW8 FBX29 |
Description | FUNCTION: Substrate-recognition component of a Cul7-RING ubiquitin-protein ligase complex, which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. The Cul7-RING(FBXW8) complex mediates ubiquitination and consequent degradation of GORASP1, acting as a component of the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain . Mediates ubiquitination and degradation of IRS1 in a mTOR-dependent manner: the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2) . The Cul7-RING(FBXW8) complex also mediates ubiquitination of MAP4K1/HPK1: recognizes and binds autophosphorylated MAP4K1/HPK1, leading to its degradation, thereby affecting cell proliferation and differentiation . Associated component of the 3M complex, suggesting that it mediates some of 3M complex functions . . |
Accessions | ENST00000455858.2 [Q8N3Y1-2] ENST00000309909.10 ENST00000652555.1 [Q8N3Y1-1] A0A499FIY5 Q8N3Y1 |